Perfil
Mr. John Ruesch is a Chief Technical Operations Officer at BioCryst Pharmaceuticals, Inc. Mr. Ruesch was previously employed as a SVP-Pharmaceutical Sciences & Technical Operations by Astria Therapeutics, Inc., a Vice President-Pharmaceutical Development by Surface Oncology, Inc., and a Senior Director-Drug Product Development by Biogen, Inc. He received his undergraduate degree from Valparaiso University and an MBA from Kellogg School of Management.
Cargos activos de John Ruesch
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/01/2026 |
Antiguos cargos conocidos de John Ruesch.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2025 |
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | 01/01/2023 |
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2021 |
Formación de John Ruesch.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Valparaiso University
Valparaiso University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
- Bolsa de valores
- Insiders
- John Ruesch
















